The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2026 | Challenges that remain when managing patients with myelofibrosis
In this video, Haifa Kathrin Al-Ali, MD, University Hospital Halle, Halle, Germany, discusses the challenges clinicians face when treating patients with myelofibrosis (MF), highlighting the need to balance treatment efficacy and safety to improve survival while also managing MF- or treatment-related anemia. This interview took place at the 31st Congress of the European Hematology Association (EHA) in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
